New Clinical Trial Suggests Daily Walnut Consumption May Support Cancer Cell Death in Women
New Clinical Trial Suggests Daily Walnut Consumption May Support Cancer Cell Death in Women
New Clinical Trial Suggests Daily Walnut Consumption May Support Cancer Cell Death in Women
A new human clinical trial has found that eating walnuts regularly may help activate cancer cell death mechanisms in women, offering fresh insight into how diet could support cancer prevention strategies.
ALSO READ: Japan’s 2,000-Year-Old Monarchy Rests on Teenage Heir as Succession Concerns Grow
Researchers observed measurable changes in tumor-related gene activity linked to apoptosis — the natural process through which damaged or abnormal cells self-destruct — after participants consumed walnuts daily. The findings suggest that compounds in walnuts may influence cellular pathways associated with cancer growth.
Walnuts are rich in polyphenols, omega-3 fatty acids, and antioxidants, nutrients known to affect inflammation and cell signaling. Scientists say these bioactive compounds appear to play a role in triggering protective responses at the molecular level.
The study builds on earlier laboratory research, including findings from Marshall University, which showed that walnut consumption can activate apoptosis-related cancer pathways. A 2019 human trial published in Nutrition Research also reported changes in breast tumor gene expression following regular walnut intake.
Experts stress that the results do not replace conventional cancer treatments. Instead, they highlight the growing importance of nutrition as a complementary tool in long-term prevention efforts.
Researchers say larger clinical trials are now being planned to better understand the lasting benefits and real-world clinical impact of walnut consumption, as universities and cancer research institutions worldwide continue exploring food-based approaches to health.
New Clinical Trial Suggests Daily Walnut Consumption May Support Cancer Cell Death in Women
